XD Zheng, Q Qu, XY Jiang… - … devices, and other …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Several clinical trials of dapagliflozin in patients with type 2 diabetes mellitus
(T2DM) at elevated cardiovascular risk have observed reduced hospitalization for heart …